在有关美联储货币政策的"专场"国会听证会次日，美联储主席鲍威尔再次提及降息前景，他重申不急于 降息，强调高关税带来很大的不确定性，因此需要观望，同时提到了可能推动降息的一些因素。 美东时间6月25日周三举行的美国参议院银行、住房和城市事务委员会听证会上，鲍威尔告诉议员，未 来的贸易协议可能会允许美联储考虑降息。 对于特朗普政府的政策，鲍威尔称，美联储上周会后公布的经济展望（SEP）更新预测在一定程度上反 映了贸易政策的影响。但关税很高，这种高关税此前没有先例，很难预料关税将如何影响通胀。在面临 不确定性的时期，更缓慢地推进货币政策是合理的。 对于通胀，鲍威尔称，滞胀并非基本的美国经济假设情形，但美联储正监控美国的价格。随着时间的推 移，监管也会造成通胀放缓。 当前高关税没有现代先例对通胀影响会在未来几个月显现 鲍威尔在作证时表示，由于缺乏历史经验，美联储官员难以评估特朗普政府贸易政策的潜在影响。"这 方面缺乏现代经验。特朗普总统第一任期内的关税规模只有现在的六分之一。" 正是由于缺乏先例，因此美联储目前对制定任何政策调整都感到不确定。鲍威尔说： "这之所以如此具有挑战性，理由之一是没有现代先例，我们必须对我们 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38232 ______________________________________________________ BlackBerry Limited (Exact name of registrant as specifi ...

CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private placement in public equity financing (the “PIPE”) that is expected to result in gross proceeds of approximately $175 million, before deducting expenses. Private Placement Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, V ...

周三（6月25日）纽约尾盘，现货黄金涨0.29%，报3333.42美元/盎司。 COMEX黄金期货涨0.40%，报3347.30美元/盎司。 COMEX铜期货涨1.14%，报4.9280美元/磅。 费城金银指数收涨0.08%，报203.97点。 现货白银涨0.99%，报36.2725美元/盎司。 COMEX白银期货涨1.38%，报36.225美元/盎司。 ...

Core Insights - Dakota Gold Corp. has published its 2024 Sustainability Report, aimed at enhancing understanding of its ESG strategy, practices, and risk management [1][2] - The report emphasizes transparency in communicating performance results to stakeholders, including shareholders and local communities [1] Group 1: Company Developments - The company has transitioned from exploration to development at the Richmond Hill Gold Project, marking a significant phase in its growth [3] - Dakota Gold has achieved four years without a lost time incident and zero reportable environmental incidents since drilling began in early 2022, highlighting its commitment to health and safety [3] Group 2: Project Focus - Dakota Gold is advancing the Richmond Hill Oxide Heap Leach Gold Project towards commercial production and is outlining a high-grade underground gold resource at the Maitland Gold Project [5]

Group 1 - The 2025 Annual and Extraordinary General Meeting of Alvotech was held on June 25, 2025, in Luxembourg [1] - All draft resolutions on the agenda of the 2025 AGM were approved [1] - Notarized meeting minutes and voting results will be published on the Company's special web portal [1]

Core Insights - Vor Bio has secured exclusive global rights (excluding Greater China) to develop and commercialize telitacicept, a dual-target recombinant fusion protein for autoimmune diseases [1][6] - RemeGen has received an initial payment of $125 million, which includes a $45 million upfront payment and $80 million in warrants, along with potential milestones exceeding $4 billion and tiered royalties [1][5] - Jean-Paul Kress, MD, has been appointed as the new CEO and Chairman of Vor Bio, bringing extensive experience in clinical development and commercialization [3][4] Company Developments - Vor Bio is focused on advancing telitacicept through Phase 3 clinical development to address serious autoantibody-driven conditions globally [7] - RemeGen is conducting a global Phase 3 clinical trial for telitacicept, with initial results expected in the first half of 2027 [2][6] - The strategic out-licensing of telitacicept's ex-China rights is aimed at maximizing its clinical and commercial potential on a global scale [5] Product Information - Telitacicept targets key immune pathways by inhibiting BlyS (BAFF) and APRIL, which are critical for B cell survival, thereby reducing autoreactive B cells and autoantibody production [2][5] - In a Phase 3 trial in China for generalized myasthenia gravis, telitacicept showed a 4.8-point improvement in the MG-ADL scale compared to placebo at 24 weeks [5]

Core Insights - Kodiak Sciences Inc. is presenting KSI-101, a bispecific investigational biologic targeting macular edema secondary to inflammation, at the 2025 Congress of the International Ocular Inflammation Society in Rio de Janeiro [1][6] - The company aims to address the significant unmet need in treating macular edema caused by inflammation, which can lead to vision loss [3][4] Company Overview - Kodiak Sciences is a precommercial biotechnology company focused on developing therapeutics for retinal diseases, utilizing its ABC Platform for innovative drug design [8][9] - The company is advancing its pipeline, which includes three late-phase clinical assets expected to deliver Phase 3 topline data in 2026 [9] Product Details - KSI-101 is a high-strength (100 mg/mL) bispecific protein designed to target both interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), addressing the dual mechanisms of macular edema [6][5] - The ongoing Phase 1b study, APEX, is evaluating the safety and tolerability of KSI-101, with plans to progress into dual Phase 2b/3 studies [7]

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights into sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]

发展多层次农业保险、完善农业保险大灾风险分散机制、推进农业保险精准投保理赔……近年来，监管 部门出台一系列政策，推动农业保险发展。在广袤的乡村大地上，保险业正发挥着越来越重要的作用。 中国证券报记者了解到，保险业通过持续创新产品、优化服务模式、深化科技赋能等措施，引金融服务 入田间地头，提升农业经营主体的抗风险能力，助力乡村全面振兴。 丰富农业保险产品体系 近年来，农业保险作为关键的风险管理工具，覆盖面与保障水平显著提升。从三大主粮作物完全成本保 险和种植收入保险，到地方特色农产品保险，农业保险产品体系日益丰富。 财政部披露的数据显示，全面实施三大粮食作物完全成本保险和种植收入保险政策，有序扩大大豆完全 成本保险和种植收入保险政策范围。全年拨付中央财政农业保险保费补贴547亿元，支持我国农业保险 保费规模1521亿元，为1.47亿户次农户提供风险保障超5万亿元。 水稻、小麦、玉米三大主粮作物承载着我国人口的口粮需求。国寿财险相关负责人表示，2024年，公司 围绕三大主粮作物的保险保障，主动作为，承保三大主粮作物种植面积超1.15亿亩，其中承保完全成本 保险约8688万亩，提供风险保障约805亿元。此外，202 ...